{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:24:29Z","timestamp":1791051869326,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.acuro.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T18:30:50Z","timestamp":1488393050000},"page":"491-496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Deprivaci\u00f3n andr\u00f3genica en c\u00e1ncer de pr\u00f3stata y riesgo de fractura a largo plazo"],"prefix":"10.1016","volume":"41","author":[{"given":"S.","family":"Ojeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lloret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Naranjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"D\u00e9niz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2017.01.005_bib0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acuro.2017.01.005_bib0130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199912093412401","article-title":"Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer","volume":"341","author":"Messing","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2017.01.005_bib0135","first-page":"499","article-title":"Contemporary hormonal management of advanced prostate cancer","volume":"12","author":"Moul","year":"1998","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"10.1016\/j.acuro.2017.01.005_bib0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","article-title":"EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease","volume":"59","author":"Heidenreich","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2017.01.005_bib0145","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1210\/jc.2005-0183","article-title":"Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer","volume":"90","author":"Greenspan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.acuro.2017.01.005_bib0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cncr.20056","article-title":"Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: Recommendations for diagnosis and therapies","volume":"100","author":"Diamond","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.acuro.2017.01.005_bib0155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0302-2838(03)00379-8","article-title":"Osteoporosis during continuous androgen deprivation: Influence of the modality and length of treatment","volume":"44","author":"Morote","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2017.01.005_bib0160","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/S0022-5347(05)00999-7","article-title":"Bone mineral density changes in patients with prostate cancer during the first 2 years of androgen suppression","volume":"175","author":"Morote","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2017.01.005_bib0165","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2017.01.005_bib0170","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-006-0160-8","article-title":"Bone fragility in men\u2013where are we","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.acuro.2017.01.005_bib0175","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2017.01.005_bib0180","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","article-title":"Case finding for the management of osteoporosis with FRAX\u2122 assessment and intervention thresholds for the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.acuro.2017.01.005_bib0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00198-009-0984-0","article-title":"Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX\u00ae","volume":"21","author":"Adler","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.acuro.2017.01.005_bib0190","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"NCCN clinical practice guidelines in oncology: Prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acuro.2017.01.005_bib0195","series-title":"Urologic pathology","first-page":"171","article-title":"Histological grading and clinical staging of prostate carcinoma","author":"Gleason","year":"1997"},{"key":"10.1016\/j.acuro.2017.01.005_bib0200","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/cncr.10492","article-title":"TNM residual tumor classification revisited","volume":"94","author":"Wittekind","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.acuro.2017.01.005_bib0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1634\/theoncologist.2007-0152","article-title":"Cancer treatment-induced bone loss: Patophysiology and clinical perspectives","volume":"13","author":"Brufsky","year":"2008","journal-title":"Oncol"},{"key":"10.1016\/j.acuro.2017.01.005_bib0210","doi-asserted-by":"crossref","first-page":"416","DOI":"10.7326\/0003-4819-146-6-200703200-00006","article-title":"Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: A randomized trial","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acuro.2017.01.005_bib0215","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1007\/s00198-013-2343-4","article-title":"Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D","volume":"24","author":"Alibhai","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.acuro.2017.01.005_bib0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2490-10-9","article-title":"A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma","volume":"10","author":"Serpa Neto","year":"2010","journal-title":"BMC Urology"},{"key":"10.1016\/j.acuro.2017.01.005_bib0225","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1464-410X.2003.04471.x","article-title":"Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation","volume":"92","author":"Hussain","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2017.01.005_bib0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.urology.2004.03.012","article-title":"Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer","volume":"64","author":"Miyaji","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.acuro.2017.01.005_bib0235","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.acuro.2014.12.004","article-title":"Calcium and phosphorus metabolism and lithogenic factors in patients with osteoporotic fracture","volume":"39","author":"Ochoa-Hortal Rull","year":"2015","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.acuro.2017.01.005_bib0240","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617300128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480617300128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T18:55:35Z","timestamp":1536000935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480617300128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0210480617300128"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2017.01.005","relation":{},"ISSN":["0210-4806"],"issn-type":[{"value":"0210-4806","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprivaci\u00f3n andr\u00f3genica en c\u00e1ncer de pr\u00f3stata y riesgo de fractura a largo plazo","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}